SCHEMBL7810089

SCHEMBL7810089

O=C(O)CCOc1cccc(N2CCN(C(=O)c3ccc(Br)cc3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
NPSR1 Q6W5P4 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.48
USP2 O75604 1/20 0.48
MAPK1 P28482 1/20 0.48
DRD2 P14416 1/20 0.47
DRD3 P35462 1/20 0.47
POLB P06746 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
SLC6A7 Q99884 1/20 0.47
PARP14 Q460N5 1/20 0.47
PARP10 Q53GL7 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817396 0.91 MAPT (0.59) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7817803 0.87 MAPT (0.55) MAPTNPSR1ITGB3ITGA2BNPC1
SCHEMBL7814051 0.86 TSHR (0.68) MAPTNPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL7811503 0.82 PARP10 (0.48) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7811446 0.81 PARP10 (0.48) NPC1LMNADRD2DRD3KMT2A
SCHEMBL7810104 0.81 LMNA (0.67) MAPTNPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL7804413 0.79 MAPT (0.60) MAPTNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7804422 0.79 SMN1; SMN2 (0.56) MAPTNPSR1SMN1; SMN2LMNATSHR
SCHEMBL7804363 0.78 ALDH1A1 (0.54) MAPTNPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL27327847 0.78 MYC (0.58) MAPTNPSR1SMN1; SMN2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed